Abiraterone Impurity Profile: Identification and Characterization of Related Substances
March 8, 2025 | News | No Comments
# Abiraterone Impurity Profile: Identification and Characterization of Related Substances ## Introduction Abiraterone acetate is a potent inhibitor of CYP17, used in the treatment of metastatic castration-resistant prostate cancer. As with any pharmaceutical compound, understanding the impurity profile of abiraterone is crucial for ensuring the safety, efficacy, and quality of the drug product. This article […]